ULNRC-05575, Submittal of Blind Sample Test Results
| ML083659358 | |
| Person / Time | |
|---|---|
| Site: | Callaway  |
| Issue date: | 12/17/2008 |
| From: | Graessle L AmerenUE |
| To: | Document Control Desk, Office of Nuclear Reactor Regulation |
| References | |
| ULNRC-05575 | |
| Download: ML083659358 (4) | |
Text
AmerenUE P0 Box 620 Cal/away Plant Fulton, MO 65251 December 17, 2008 ULNRC-05575 U.S. Nuclear Regulatory Commission Attn: Document Control Desk Mail Stop P1-137 Washington, DC 20555-0001 S10CFR26, Appendix A, 2.8 (e) (3) and (4)
WA meren UE Ladies and Gentlemen:
DOCKET NUMBER 50-483 CALLAWAY PLANT UNIT 1 UNION ELECTRIC CO.
FACILITY OPERATING LICENSE NPF-30 Blind Sample Test Results On 11/19/2008, the Callaway Medical Review Officer discovered that a blind performance test result received from the University of Missouri Toxicology and Drug Monitoring Laboratory was not consistent with what was expected to be reported. The report did not identify that the blind sample was adulterated. The laboratory is a Department of Health and Human Services (DHHS) laboratory.
In accordance with 10CFR26, Appendix A, 2.8 (e) (3) and (4), enclosed is the documentation of investigative findings and the corrective actions taken by the University of Missouri, Toxicology and Drug Monitoring Laboratory. Please contact Anna Lee at 573/676-4435 if any additional action is needed as a result of this information.
This letter does not contain any new commitments.
Sincerely, Luke H Graessle, Director, Operations Support CSP/nls Enclosure
/tO, a subsidiary of Ameren Corporation
ULNRC-05575 December 17, 2008 Page 2 cc:
Mr. Elmo E. Collins, Jr.
Regional Administrator U.S. Nuclear Regulatory Commission Region IV 612 E. Lamar Blvd., Suite 400 Arlington, TX 76011-4125 Senior Resident Inspector Callaway Resident Office U.S. Nuclear Regulatory Commission 8201 NRC Road Steedman, MO 65077 Mr. Mohan C. Thadani (2 copies)
Licensing Project Manager, Callaway Plant Office of Nuclear Reactor Regulation U. S. Nuclear Regulatory Commission Mail Stop O-8G14 Washington, DC 20555-2738
ULNRC-05575 December 17, 2008 Page 3 Index and send hardcopy to QA File A160.0761 Hardcopy:
Certrec Corporation 4200 South Hulen, Suite 422 Fort Worth, TX 76109 (Certrec receives ALL attachments as long as they are non-safeguards and may be publicly disclosed.)
Electronic distribution for the following can be made via Other Situations ULNRC Distribution:
A. C. Heflin F. M. Diya T. E. Herrmann L. S. Sandbothe S. A. Maglio S. L. Gallagher L. M. Belsky (NSRB)
T. B. Elwood L. H. Graessle A. M. Lee C. S. Petzel Ms. Diane M. Hooper (WCNOC)
Mr. Dennis Buschbaum (TXU)
Mr. Scott Bauer (Palo Verde)
Mr. Stan Ketelsen (PG&E)
Mr. Wayne Harrison (STPNOC)
Mr. John O'Neill (Pillsbury Winthrop Shaw Pittman LLP)
Missouri Public Service Commission
DEC-03-2008 13:45 UVIC TOXICOLOGY LAD 673 884 4917 P.002 University of Missouri Toxicology snd Drug Enclosure H
CARE Monitoring Laboratory to ULNRC-05575 301 Buirwess Loop 70 Wet Suitc 208 Columbia. MO 65203 ruoONm 573-832-1273 r-AX S73-884-4917 Documentation of Blind Specimen Reporting Error Sample ID - 81818 Accession number - 206253108 Collection date - 11/14/08 Received date - 11/14/08 Reported date - 11/19/08 Initial reported results - Cannabinolds positive at 20 ng/ml level Corrected results - Cannabirnoids positive at 20 ng/ml and adulterated pH = 2.2 Description of error:
The adulteration remark was initially omitted from the report. The specimen validity had been performed on the day of the Initial screening but was omitted by the screening technologist from the daily worksheet. After the confirmation of the cannabinoids by GC/MS the certifying scientist reviewed the EMIT screening data, the GO/MS data. internal/external chain of custodies, primary bottle identification, and worksheet data. Because the additional specimen validity testing data was not on the daily worksheet, the adulteration reporting was not completed-One major factor contributed to this error. The laboratory had gone "live" with a new laboratory information system (Cemer Millenium) on 11/15/08. The staff of the laboratory were still acclimating to this new system. After the 'go-live", there were a multitude of problems in the computer system that was causing the normal workflow in the laboratory to be disrupted by these minor issues. During these initial days, technologists were still getting used to new labels, worklists, worksheets, and accession number formats. It was during this time that the pH specimen validity testing on this sample was omitted from the daily worksheet.
Corrective action:
Following the identification of the error, the certifying scientist faxed to Ameren UE the raw data docum ation related to the testing of this sample providing evidence that the sample was corr tested and the final.reported information was accurate. The importance of documenting all t ti g on the daily worksheet was discussed with the screening technologist. No other cor e action is planned at this time.
S harles A. Johnson Toxicology and Drug Monitoring Laboratory 301 Business Loop 70 West, Ste. 208 Columbia, MO. 65203 REC'D DEC 0 3 2008 Univ oer iy p tsitly -
a'g Ho.qpbX.
-IU F vhel CI rCanLzr - i:o uJ, i lhiLsicm Ceion
.ter Columbia Ra -ih fw ilospital -RuskiP habii.Lio Ccncr. Cr i.ap;l K d,, Medical Centcr Coop*r Ctwxy Memorial Hospital - tInivwMty Phuioi=m-MU Nhkk l oF'Mcdicinc?-MU incdir School ofNursix i-MtflIchnnl or-hen1bro
.*(dn At 10)11m, 0maruawim/ADA mkSrtIn'wLr4 TOTAL P.002